SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-17-009315
Filing Date
2017-09-14
Accepted
2017-09-14 17:13:43
Documents
3
Period of Report
2017-09-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 a8kpressreleasereprelimdat.htm 8-K 30062
2 EXHIBIT 99.1 iaslcchicagodata.htm EX-99.1 25683
3 miratilogopurplev3.jpg GRAPHIC 9622
  Complete submission text file 0001628280-17-009315.txt   69919
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 171086255
SIC: 2834 Pharmaceutical Preparations